Novo A/S (CIK 0001388325)

Latest company ownership

Shares held
6,071,703
Last filed at
Sep 16, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
IOBT - IO Biotech, Inc.
Role: 10% Owner
Shares held
4,354,449
Last filed at
Jul 26, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
3,703,991
Last filed at
Jul 15, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
3,330,337
Last filed at
Jun 23, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
2,550,000
Last filed at
Mar 25, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
2,459,021
Last filed at
Feb 19, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
2,434,470
Last filed at
Nov 27, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
INGN - Inogen Inc
Role: 10% Owner
Shares held
2,079,320
Last filed at
Jun 3, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4
Shares held
2,007,449
Last filed at
Oct 26, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q4 2025Q4
ANAB - ANAPTYSBIO, INC
Role: 10% Owner
Shares held
1,936,604
Last filed at
Aug 21, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
1,870,147
Last filed at
Jul 23, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
NKTX - Nkarta, Inc.
Role: 10% Owner
Shares held
1,712,811
Last filed at
Jul 16, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
1,389,498
Last filed at
Jul 9, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q1 2025Q4
Shares held
1,333,797
Last filed at
Mar 26, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4
Shares held
1,174,682
Last filed at
Oct 30, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2025Q4 2025Q4
IRON - Disc Medicine, Inc.
Role: 10% Owner
Shares held
1,090,772
Last filed at
Jun 28, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4
MGX - Metagenomi, Inc.
Role: 10% Owner
Shares held
691,760
Last filed at
Feb 15, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4
ACLX - Arcellx, Inc.
Role: 10% Owner
Shares held
433,196
Last filed at
Feb 9, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4
GLTO - Galecto, Inc.
Role: 10% Owner
Shares held
257,188
Last filed at
Nov 4, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
242,588
Last filed at
Sep 4, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
241,219
Last filed at
Oct 22, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
0
Last filed at
Oct 12, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 28, 2025 Oct 30, 2025 MapLight Therapeutics, Inc. 10% Owner Buy 100.0 +952,941 34.86% ✗ $16.2M
Jul 25, 2024 Jul 26, 2024 IO Biotech, Inc. 10% Owner Sell 22.5 -75,000 -1.69% ✗ $99.1K
May 10, 2024 May 14, 2024 IO Biotech, Inc. 10% Owner Sell 20.0 -658,809 -12.95% ✗ $802.5K
Mar 21, 2024 Mar 25, 2024 SPRUCE BIOSCIENCES, INC. 10% Owner Sell 20.0 -465,021 -15.42% ✗ $351K
Mar 18, 2024 Mar 20, 2024 SPRUCE BIOSCIENCES, INC. 10% Owner Sell 17.5 -1,794,999 -37.32% ✗ $1.4M
Mar 14, 2024 Mar 18, 2024 SPRUCE BIOSCIENCES, INC. 10% Owner Sell 17.5 -1,912,316 -28.45% ✗ $1.7M
Feb 9, 2024 Feb 15, 2024 Metagenomi, Inc. 10% Owner Buy 100.0 +900,000 95.83% ✗ $13M
Feb 9, 2024 Feb 13, 2024 IO Biotech, Inc. 10% Owner Sell 20.0 -658,809 -11.46% ✗ $988.4K
Aug 9, 2023 Aug 11, 2023 IO Biotech, Inc. 10% Owner Buy 100.0 +2,469,135 76.25% ✗ $5M
Jun 28, 2023 Jun 28, 2023 Disc Medicine, Inc. 10% Owner Sell 15.0 -1,250,000 -53.40% ✗ $57.6M
Jun 23, 2023 Jun 23, 2023 OnKure Therapeutics, Inc. 10% Owner Sell 20.0 -100,000 -2.92% ✗ $709.7K
Feb 16, 2023 Feb 21, 2023 SPRUCE BIOSCIENCES, INC. 10% Owner Buy 100.0 +2,208,000 48.91% ✗ $7M
Sep 14, 2022 Sep 16, 2022 Edgewise Therapeutics, Inc. 10% Owner Buy 95.0 +484,496 8.67% ✗ $5M
Jul 13, 2022 Jul 15, 2022 Bolt Biotherapeutics, Inc. 10% Owner Sell 17.5 -800,000 -17.76% ✗ $1.6M
Feb 8, 2022 Feb 9, 2022 Arcellx, Inc. 10% Owner Buy 100.0 +833,333 26.18% ✗ $12.5M
Nov 9, 2021 Nov 10, 2021 IO Biotech, Inc. 10% Owner Buy 100.0 +325,000 11.01% ✗ $4.6M
Jun 2, 2021 Jun 3, 2021 Inogen Inc 10% Owner Sell 15.0 -680,000 -24.64% ✗ $39M
May 19, 2021 May 21, 2021 SPRUCE BIOSCIENCES, INC. 10% Owner Sell 16.3 -475,000 -9.52% ✗ $6.6M
Apr 13, 2021 Apr 14, 2021 OnKure Therapeutics, Inc. 10% Owner Buy 100.0 +666,666 24.12% ✗ $10M
Mar 30, 2021 Mar 31, 2021 Edgewise Therapeutics, Inc. 10% Owner Buy 100.0 +625,000 12.60% ✗ $10M
Mar 1, 2021 Mar 3, 2021 Inogen Inc 10% Owner Sell 15.0 -790,000 -22.26% ✗ $38.7M
Feb 18, 2021 Feb 19, 2021 Galera Therapeutics, Inc. 10% Owner Sell 16.3 -500,000 -16.90% ✗ $5.3M
Feb 9, 2021 Feb 11, 2021 Bolt Biotherapeutics, Inc. 10% Owner Buy 96.3 +400,000 9.75% ✗ $8M
Nov 2, 2020 Nov 4, 2020 Galecto, Inc. 10% Owner Buy 100.0 +333,333 15.40% ✗ $5M
Oct 20, 2020 Oct 22, 2020 Aligos Therapeutics, Inc. 10% Owner Buy 95.0 +200,000 8.28% ✗ $3M
Oct 15, 2020 Oct 19, 2020 Galera Therapeutics, Inc. 10% Owner Sell 17.5 -450,000 -13.20% ✗ $5M
Oct 14, 2020 Oct 16, 2020 SPRUCE BIOSCIENCES, INC. 10% Owner Buy 95.0 +250,000 5.28% ✗ $3.8M
Aug 21, 2020 Aug 25, 2020 Harmony Biosciences Holdings, Inc. 10% Owner Buy 92.5 +132,503 3.10% ✗ $3.2M
Jul 14, 2020 Jul 16, 2020 Nkarta, Inc. 10% Owner Buy 100.0 +555,555 24.82% ✗ $10M
Jul 7, 2020 Jul 9, 2020 Corvus Pharmaceuticals, Inc. 10% Owner Sell 16.3 -1,538,062 -52.54% ✗ $8.2M
Nov 25, 2019 Nov 27, 2019 Milestone Pharmaceuticals Inc. 10% Owner Sell 17.5 -240,000 -8.97% ✗ $3.8M
Nov 12, 2019 Nov 14, 2019 Galera Therapeutics, Inc. 10% Owner Buy 100.0 +500,000 17.19% ✗ $6M
Jul 23, 2019 Jul 25, 2019 Corvus Pharmaceuticals, Inc. 10% Owner Sell 16.3 -1,492,956 -33.77% ✗ $6.1M
Jul 22, 2019 Jul 23, 2019 Mirum Pharmaceuticals, Inc. 10% Owner Buy 100.0 +575,000 30.75% ✗ $8.6M
May 13, 2019 May 14, 2019 Milestone Pharmaceuticals Inc. 10% Owner Buy 100.0 +333,333 14.24% ✗ $5M
Mar 12, 2018 Mar 13, 2018 Corvus Pharmaceuticals, Inc. 10% Owner Buy 100.0 +1,176,470 36.27% ✗ $10M
Oct 10, 2017 Oct 12, 2017 KalVista Pharmaceuticals, Inc. 10% Owner Sell 15.0 -2,725,283 -100.00% ✗ $26.3M
Sep 13, 2017 Sep 18, 2017 KalVista Pharmaceuticals, Inc. 10% Owner Sell 17.5 -176,644 -6.09% ✗ $1.3M
Sep 13, 2017 Sep 15, 2017 KalVista Pharmaceuticals, Inc. 10% Owner Sell 17.5 -176,647 -6.09% ✗ $1.3M
Aug 21, 2017 Aug 21, 2017 ANAPTYSBIO, INC 10% Owner Sell 16.3 -356,300 -15.54% ✗ $7.5M
Aug 14, 2017 Aug 16, 2017 ANAPTYSBIO, INC 10% Owner Sell 17.5 -178,600 -7.23% ✗ $3.8M
Aug 4, 2017 Aug 8, 2017 ANAPTYSBIO, INC 10% Owner Sell 15.0 -491,294 -16.58% ✗ $10.4M
Aug 1, 2017 Aug 3, 2017 ANAPTYSBIO, INC 10% Owner Sell 17.5 -70,706 -2.33% ✗ $1.6M
Jun 23, 2017 Jun 27, 2017 Corvus Pharmaceuticals, Inc. 10% Owner Buy 72.5 +20,000 0.62% ✗ $219K
Jan 31, 2017 Feb 1, 2017 ANAPTYSBIO, INC 10% Owner Buy 85.0 +50,000 1.68% ✗ $750K
Oct 25, 2016 Oct 26, 2016 iRhythm Technologies, Inc. 10% Owner Buy 92.5 +100,000 4.94% ✗ $1.7M
May 12, 2016 May 16, 2016 Corvus Pharmaceuticals, Inc. 10% Owner Buy 85.0 +70,000 2.22% ✗ $700K
Mar 29, 2016 Mar 30, 2016 Corvus Pharmaceuticals, Inc. 10% Owner Buy 100.0 +666,666 26.80% ✗ $10M
Nov 4, 2014 Nov 5, 2014 Inogen Inc 10% Owner Sell 15.0 -2,000,000 -36.04% ✗ $43M
Mar 25, 2014 Mar 26, 2014 Akebia Therapeutics, Inc. 10% Owner Buy 100.0 +182,590 13.69% ✗ $3.1M
Feb 20, 2014 Feb 24, 2014 Inogen Inc 10% Owner Sell 16.3 -617,000 -10.22% ✗ $9.2M